PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Institute of Applied Health Research, University of Birmingham, Birmingham, UK.\', \'Cegedim Health Data, Cegedim Rx, London, UK.\', \'The Health Improvement Network (THIN), London, UK.\', \'Department of Diabetes, Gartnavel General Hospital, NHS Greater Glasgow and Clyde, Glasglow, UK.\', \'Birmingham Acute Care Research Group, Institute of Inflammation and Ageing, University of Birmingham, Birmingham, UK.\', \'Department of Acute Medicine, Queen Elizabeth Hospital Birmingham, Birmingham, UK.\', \'PIONEER, The Health Data Research UK Hub in Acute Care, Birmingham, UK.\', \'Institute of Applied Health Research, University of Birmingham, Birmingham, UK. N.J.Adderley@bham.ac.uk.\', \'Department of Diabetes and Endocrinology, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK.\', \'Midlands Health Data Research UK, Birmingham, UK.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1186/s12879-021-05951-w
?:hasPublicationType
?:journal
  • BMC infectious diseases
is ?:pmid of
?:pmid
?:pmid
  • 33722197
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.576
?:rankingScore_hIndex
  • 80
?:title
  • Renin-angiotensin system inhibitors and susceptibility to COVID-19 in patients with hypertension: a propensity score-matched cohort study in primary care.
?:type
?:year
  • 2021

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/33722197>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/33722197>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all